<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Weinberg GroupThe Weinberg Group | The Weinberg Group</title>
	<atom:link href="http://weinberggroup.com/index.php/feed/" rel="self" type="application/rss+xml" />
	<link>http://weinberggroup.com</link>
	<description>The Weinberg Group has assisted pharma, biotech and device clients in the development and implementation of successful and innovative regulatory strategies. In addition, we have worked with hundreds of companies to remediate, maintain and improve their regulatory compliance.</description>
	<lastBuildDate>Thu, 16 Feb 2012 19:58:12 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Weinberg Group representative to be in San Francisco February 13-17</title>
		<link>http://weinberggroup.com/index.php/weinberg-group-representative-to-be-in-san-francisco-february-13-17/</link>
		<comments>http://weinberggroup.com/index.php/weinberg-group-representative-to-be-in-san-francisco-february-13-17/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 16:51:01 +0000</pubDate>
		<dc:creator>Weinberg-admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://weinberggroup.com/?p=268</guid>
		<description><![CDATA[We will be meeting with current and prospective clients in San Francisco from Monday, February 13 until Friday, February 17. If you would like to learn more about how The Weinberg Group assists clients to develop and implement successful regulatory and compliance strategies and please contact Greg Stevens at greg.stevens@weinberggroup.com.]]></description>
			<content:encoded><![CDATA[<p>We will be meeting with current and prospective clients in San Francisco from Monday, February 13 until Friday, February 17. If you would like to learn more about how The Weinberg Group assists clients to develop and implement successful regulatory and compliance strategies and please contact Greg Stevens at <a href="mailto:greg.stevens@weinberggroup.com"><span style="color: #352c66;"><strong>greg.stevens@weinberggroup.com</strong></span></a>.<br />
<BR><BR><BR></p>
]]></content:encoded>
			<wfw:commentRss>http://weinberggroup.com/index.php/weinberg-group-representative-to-be-in-san-francisco-february-13-17/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Weinberg Group to Sponsor and Participate in Linking Leaders Roundtable Series</title>
		<link>http://weinberggroup.com/index.php/weinberg-group-to-sponsor-and-participate-in-linking-leaders-roundtable-feb-1-2-2012/</link>
		<comments>http://weinberggroup.com/index.php/weinberg-group-to-sponsor-and-participate-in-linking-leaders-roundtable-feb-1-2-2012/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 21:11:19 +0000</pubDate>
		<dc:creator>Weinberg-admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://weinberggroup.com/?p=258</guid>
		<description><![CDATA[Linking Leaders’ Clinical Quality roundtable series provides pharmaceutical and biotech executives a forum to share insights and experiences, benchmark progress, and collaborate on solutions with like-minded peers facing similar industry obstacles in a closed-door, invitation-only setting. This unique forum brings together an exclusive community of executives engaged in Clinical Quality Assurance, Compliance, Risk Management and more to discuss collective challenges and collaborate on new ways to spearhead innovation in executing quality in clinical trials. The Weinberg Group is sponsoring the 2012 quarterly roundtable meetings with Amy Hansen, Director of GCP Services, joining the pharma executive network members at the boardroom table. For more information please visit www.linkingleaders.com.]]></description>
			<content:encoded><![CDATA[<p>Linking Leaders’ Clinical Quality roundtable series provides pharmaceutical and biotech executives a forum to share insights and experiences, benchmark progress, and collaborate on solutions with like-minded peers facing similar industry obstacles in a closed-door, invitation-only setting. This unique forum brings together an exclusive community of executives engaged in Clinical Quality Assurance, Compliance, Risk Management and more to discuss collective challenges and collaborate on new ways to spearhead innovation in executing quality in clinical trials. </p>
<p>The Weinberg Group is sponsoring the 2012 quarterly roundtable meetings with Amy Hansen, Director of GCP Services, joining the pharma executive network members at the boardroom table. For more information please visit <a href="http://www.linkingleaders.com" title="www.linkingleaders.com"><span style="color: #352c66;"><strong>www.linkingleaders.com</strong></span></a>.<br />
<BR><BR><BR></p>
]]></content:encoded>
			<wfw:commentRss>http://weinberggroup.com/index.php/weinberg-group-to-sponsor-and-participate-in-linking-leaders-roundtable-feb-1-2-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Weinberg Group Launches its Blog</title>
		<link>http://weinberggroup.com/index.php/new-blog/</link>
		<comments>http://weinberggroup.com/index.php/new-blog/#comments</comments>
		<pubDate>Wed, 14 Dec 2011 16:28:31 +0000</pubDate>
		<dc:creator>Weinberg-admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://weinberggroup.com/?p=152</guid>
		<description><![CDATA[The Weinberg Group is excited to announce the publication of its new blog, Weinberg on FDA.  The blog will act as a forum for discussion among our experienced consultants and the regulatory community.  Each week, Weinberg on FDA will feature opinions and discussion on FDA news and regulatory decisions from some of our most senior consultants, including Nick Fleischer, Joel Falk and Bob Roth. As we continue to provide clients with exceptional service and results, we believe this blog will allow the public to become familiar with The Weinberg Group, our knowledge and our work.  We have also joined the discussion on Facebook and Twitter and look forward to sharing company activities, announcements and thoughts with our followers on a daily basis. Weinberg on FDA Twitter Facebook &#160;]]></description>
			<content:encoded><![CDATA[<p>The Weinberg Group is excited to announce the publication of its new blog, <b>Weinberg on FDA</b>.  The blog will act as a forum for discussion among our experienced consultants and the regulatory community.  Each week, Weinberg on FDA will feature opinions and discussion on FDA news and regulatory decisions from some of our most senior consultants, including Nick Fleischer, Joel Falk and Bob Roth.</p>
<p>As we continue to provide clients with exceptional service and results, we believe this blog will allow the public to become familiar with The Weinberg Group, our knowledge and our work.  We have also joined the discussion on Facebook and Twitter and look forward to sharing company activities, announcements and thoughts with our followers on a daily basis.</p>
<p><a href="http://www.weinbergonfda.com/">Weinberg on FDA</a><br />
<a href="http://www.twitter.com/weinberggroup">Twitter</a><br />
<a href="https://www.facebook.com/pages/The-Weinberg-Group/297376910286047">Facebook</a></p>
<p>&nbsp;<BR><BR><BR></p>
]]></content:encoded>
			<wfw:commentRss>http://weinberggroup.com/index.php/new-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

